Related references
Note: Only part of the references are listed.Spironolactone in Post-Transplant Proteinuria: A Safe Alternative Therapy
M. V. de Sousa et al.
TRANSPLANTATION PROCEEDINGS (2017)
Does Mineralocorticoid Receptor Antagonism Prevent Calcineurin Inhibitor-Induced Nephrotoxicity?
Line Aas Mortensen et al.
FRONTIERS IN MEDICINE (2017)
Randomized Controlled Trial of Mineralocorticoid Receptor Blockade in Children with Chronic Kidney Allograft Nephropathy
Mara Medeiros et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Calcineurin Inhibitor Nephrotoxicity Through the Lens of Longitudinal Histology: Comparison of Cyclosporine and Tacrolimus Eras
Brian J. Nankivell et al.
TRANSPLANTATION (2016)
Safety of Eplerenone for Kidney-Transplant Recipients with Impaired Renal Function and Receiving Cyclosporine A
Jean-Philippe Bertocchio et al.
PLOS ONE (2016)
Emerging Roles of the Mineralocorticoid Receptor in Pathology: Toward New Paradigms in Clinical Pharmacology
F. Jaisser et al.
PHARMACOLOGICAL REVIEWS (2016)
Aldosterone antagonists for preventing the progression of chronic kidney disease
Davide Bolignano et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2014)
Mineralocorticoid Receptor Blockade Reduced Oxidative Stress in Renal Transplant Recipients: A Double-Blind, Randomized Pilot Study
Marcos Ojeda-Cervantes et al.
AMERICAN JOURNAL OF NEPHROLOGY (2013)
Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis
Nancy J. Brown
NATURE REVIEWS NEPHROLOGY (2013)
The mineralocorticoid receptor antagonist eplerenone reduces renal interstitial fibrosis after long-term cyclosporine treatment in rat: antagonizing cyclosporine nephrotoxicity
Finn Thomsen Nielsen et al.
BMC NEPHROLOGY (2013)
Influence of Baseline and Worsening Renal Function on Efficacy of Spironolactone in Patients With Severe Heart Failure
Orly Vardeny et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Cellular and molecular mechanisms of renal fibrosis
Youhua Liu
NATURE REVIEWS NEPHROLOGY (2011)
Moderate Antiproteinuric Effect of Add-On Aldosterone Blockade with Eplerenone in Non-Diabetic Chronic Kidney Disease. A Randomized Cross-Over Study
Lene Boesby et al.
PLOS ONE (2011)
Addition of Spironolactone to Dual Blockade of Renin Angiotensin System Dramatically Reduces Severe Proteinuria in Renal Transplant Patients: An Uncontrolled Pilot Study at 6 Months
E. Gonzalez Monte et al.
TRANSPLANTATION PROCEEDINGS (2010)
Inhibition of mineralocorticoid receptors with eplerenone alleviates short-term cyclosporin A nephrotoxicity in conscious rats
Finn Thomsen Nielsen et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2008)
Effects of spironolactone in an experimental model of chronic cyclosporine nephrotoxicity
B. Macunluoglu et al.
TRANSPLANTATION PROCEEDINGS (2008)
Mineralocorticoid receptor blockade confers renoprotection in preexisting chronic cyclosporine nephrotoxicity
Jazmin Perez-Rojas et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2007)
Assessment of changes in kidney allograft function using creatinine-based estimates of glomerular filtration rate
M. Gera et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
Renocortical mRNA expression of vasoactive factors during spironolactone protective effect in chronic cyclosporine nephrotoxicity
JM Pérez-Rojas et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2005)
Long-term deterioration of kidney allograft function
BL Kasiske et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Calcineurin inhibitor nephrotoxicity: Longitudinal assessment by protocol histology
BJ Nankivell et al.
TRANSPLANTATION (2004)
Rates of hyperkalemia after publication of the randomized aldactone evaluation study
DN Juurlink et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Guidelines for the measurement of glomerular filtration rate using plasma sampling
JS Fleming et al.
NUCLEAR MEDICINE COMMUNICATIONS (2004)
The change in allograft function among long-term kidney transplant recipients
JS Gill et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction
B Pitt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Therapeutic benefit of spironolactone in experimental chronic cyclosporine A nephrotoxicity
I Feria et al.
KIDNEY INTERNATIONAL (2003)
Measurements of cortical interstitium in biopsies from human kidney grafts: how representative and how reproducible?
AR Ellingsen et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2002)
Share Paper
